Drug Discovery Statistics

Steve Goldstein
Steve Goldstein
Business Formation Expert
Steve Goldstein runs LLCBuddy, helping entrepreneurs set up their LLCs easily. He offers clear guides, articles, and FAQs to simplify the process. His team keeps everything accurate and current, focusing on state rules, registered agents, and compliance. Steve’s passion for helping businesses grow makes LLCBuddy a go-to resource for starting and managing an LLC.

All Posts by Steve Goldstein →
Business Formation Expert  |   Fact Checked by Editorial Staff
Last updated: 
LLCBuddy™ offers informative content for educational purposes only, not as a substitute for professional legal or tax advice. We may earn commissions if you use the services we recommend on this site.
At LLCBuddy, we don't just offer information; we provide a curated experience backed by extensive research and expertise. Led by Steve Goldstein, a seasoned expert in the LLC formation sector, our platform is built on years of hands-on experience and a deep understanding of the nuances involved in establishing and running an LLC. We've navigated the intricacies of the industry, sifted through the complexities, and packaged our knowledge into a comprehensive, user-friendly guide. Our commitment is to empower you with reliable, up-to-date, and actionable insights, ensuring you make informed decisions. With LLCBuddy, you're not just getting a tutorial; you're gaining a trustworthy partner for your entrepreneurial journey.

Drug Discovery Statistics 2023: Facts about Drug Discovery outlines the context of what’s happening in the tech world.

LLCBuddy editorial team did hours of research, collected all important statistics on Drug Discovery, and shared those on this page. Our editorial team proofread these to make the data as accurate as possible. We believe you don’t need to check any other resources on the web for the same. You should get everything here only 🙂

Are you planning to form an LLC? Maybe for educational purposes, business research, or personal curiosity, whatever the reason is – it’s always a good idea to gather more information about tech topics like this.

How much of an impact will Drug Discovery Statistics have on your day-to-day? or the day-to-day of your LLC Business? How much does it matter directly or indirectly? You should get answers to all your questions here.

Please read the page carefully and don’t miss any words.

Top Drug Discovery Statistics 2023

☰ Use “CTRL+F” to quickly find statistics. There are total 10 Drug Discovery Statistics on this page 🙂

Drug Discovery “Latest” Statistics

  • The estimated median capitalized research and development cost per product in a particular study, which included 63 of 355 new therapeutic drugs and biologic agents approved by the US Food and Drug Administration between 2009 and 2018, was $1.1 billion, including costs associated with unsuccessful trials.[1]
  • The pharmaceutical industry spent $83 billion on research and development in 2019.[2]
  • The number of new drugs approved for sale increased by 60% between 2010 and 2019, reaching a peak of 59 in 2018.[2]
  • It has been estimated that developing a new drug will cost anywhere from less than $1 billion to more than $2 billion, which includes expenditures on drugs that do not reach the market and capital costs.[2]
  • The global market was predicted to be worth approximately $188 billion in 2022 and nearly $300 billion in 2026.[3]
  • The market for drug discovery is anticipated to be worth 71 billion US dollars by 2025.[4]
  • The market for drug discovery was only worth 35.2 billion US dollars in 2016.[4]
  • The FDA granted approval to 355 brand-new drugs and biologics between 2009 and 2018.[1]
  • The median and mean research and development investments required to bring a new drug to the market were estimated to be $1142 million and $1559 million, respectively, based on data for 63 therapeutic agents developed by 47 companies between 2009 and 2018.[1]
  • Based on a sample of ten drugs, Prasad and Mailankody estimated in 2017 that the median cost of bringing a single cancer drug to market through research and development was $780 million (in 2018 US dollars), capitalized at a real cost of capital rate of 7% per year.[1]

Also Read

How Useful is Drug Discovery

The usefulness of drug discovery cannot be understated, as it plays a crucial role in addressing the growing burden of diseases such as cancer, cardiovascular diseases, autoimmune disorders, and infectious diseases. By uncovering new drugs that target specific molecular pathways and biological processes, researchers are able to provide patients with more effective and tailored treatment options that can significantly improve their health outcomes.

One of the key benefits of drug discovery is its ability to revolutionize the way diseases are treated. For instance, the development of targeted therapies has enabled healthcare professionals to identify the underlying causes of certain diseases at a molecular level, allowing for more precise and personalized treatment approaches. This not only improves the efficacy of treatments but also reduces the risk of side effects and adverse reactions that are commonly associated with traditional broad-spectrum medications.

Furthermore, drug discovery has played a pivotal role in addressing emerging health threats such as antibiotic resistance and infectious disease outbreaks. By continuously researching and developing new antimicrobial agents, researchers are able to stay ahead of evolving pathogens and prevent the spread of drug-resistant strains that pose a significant public health risk. This proactive approach to drug discovery is essential in safeguarding global health and protecting populations from the devastating consequences of infectious diseases.

Moreover, drug discovery has the potential to enhance our understanding of disease mechanisms and pathophysiology, leading to groundbreaking discoveries and medical breakthroughs. Through the study of novel drug targets and pathways, researchers are able to uncover valuable insights into the complex interactions that drive disease progression, paving the way for the development of innovative treatment strategies and diagnostic tools that can transform patient care.

In addition, the economic impact of drug discovery cannot be overlooked. The pharmaceutical industry generates billions of dollars in revenue from the development and sale of new drugs, fueling innovation and driving economic growth. This not only supports the sustainability of research and development efforts but also creates job opportunities, fosters scientific collaborations, and promotes technological advancements that benefit society as a whole.

Despite these significant advantages, drug discovery does face challenges and limitations that hinder its full potential. The process of discovering and developing new drugs is time-consuming, costly, and often fraught with uncertainty, as many promising candidates may fail to meet safety and efficacy standards during clinical trials. Regulatory hurdles, ethical considerations, and market pressures also pose obstacles to the successful translation of research findings into viable treatment options.

Overall, the utility of drug discovery in improving healthcare outcomes and advancing medical science cannot be disputed. As we continue to push the boundaries of scientific innovation and collaboration, it is crucial to invest in research and development efforts that will drive the discovery of new drugs and therapies that have the power to transform lives and revolutionize healthcare as we know it.


  1. jamanetwork – https://jamanetwork.com/journals/jama/fullarticle/2762311
  2. cbo – https://www.cbo.gov/publication/57126
  3. ox – https://www.ox.ac.uk/research/research-impact/statistical-expertise-drug-discovery
  4. statista – https://www.statista.com/statistics/765535/drug-discovery-market-worldwide-by-segment-globally/

Leave a Comment